Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

42,576 stories, page 532 of 710

Advanced search

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Denmark urged to rework confidential drug pricing pilot

The Pharma LetterOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Regulatory round-up: 13 July 2026

The Pharma LetterOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Iqirvo broadens liver disease case with Phase III result

The Pharma LetterOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2027

marketscreener.comOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Cambridge biotech files for IPO as it awaits FDA decision on sleep apnea pill

The Business JournalsOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

The Wrong Way To Compete With China in Biotech

RealClearDefenseOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Teva Pharmaceutical Industries Ltd. $TEVA Position Increased by Sequoia Financial Advisors LLC

MarketBeatOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of the Fiscal Year Ending May 31, 2027

marketscreener.comOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

FedEx launches dedicated life sciences organisation

Air Cargo NewsOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical (TAK) Launches Plasma Ecosystem Initiative in Indonesia

GuruFocusOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Returns Matter: NUTX +214%, CORT +145%, GKOS +97% - Were These Biotech Stocks In Your Portfolio?

RTTNewsOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

FDA proposal to modernize drug manufacturing registration

The Pharma LetterOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Erie clinical trial for eye medicine gives Pittsburgh-area man hope

Erie Times-NewsOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Appeal by Huaheng biotech group against EU duties on Chinese valine released

MLexOriginal source

🇺🇰Jul 13Regulatorygov.ukTier 1 · Regulatory source

DHSC: senior officials’ business expenses, hospitality and meetings, October to December 2025

All data on senior officials’ business expenses, external meetings and hospitality.

UK Department of Health and Social CareOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Building the foundation for the orchestrated lab of the future

European Pharmaceutical ReviewOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

JPMorgan resumes Legend Biotech stock coverage with neutral rating

Investing.comOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Cabinet launches plan to attract foreign workers for AI, biotech

DutchNews.nlOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

IN8bio Publishes Positive Phase 1 GBM Data

t.coOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

LEO Pharma Reports Positive Phase 2 Tralokinumab Results

t.coOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Once‑monthly VWD shot from Incyte slashes bleeding in early trial

Stock TitanOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Drugmaker Vertex spends $10B to buy biotech firm to expand rare-disease offerings

Post and CourierOriginal source

🌍Jul 13discoverynews.google.comTier 2 · Trade media

Top emerging biotech hubs in 2026

Fierce BiotechOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Candriam S.C.A. Makes New Investment in Teva Pharmaceutical Industries Ltd. $TEVA

MarketBeatOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

FDA Fast-Track Designation for Arialys' Anti-NMDA Therapy

AllSciOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

MBRX Q1 2026 Earnings: Wider-than-Expected Loss as Clinical-Stage Biotech Continues Pipeline Development

dars.gov.etOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

PureTech Subsidiary Celea Begins Phase 3 IPF Study Comparing Deupirfenidone With Standard Therapy (PRTC)

Yahoo Finance UKOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Dimerix (ASX:DXB) Shares Slip: Is the Market Underestimating the Biotechnology Company's Clinical Pipeline?

KalkineOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Price to sales forward of Tibet Rhodiola Pharmaceutical Holding Co. Class A – SSE:600211

TradingViewOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Navigating The New EU Pharmaceutical Legislation Key Implications For Pediatric Drug Development

Clinical LeaderOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of KINTOR PHARMACEUTICAL LTD. – OTC:KNTPF

TradingViewOriginal source

🇸🇬Jul 13Regulatoryapacmed.orgTier 1 · Regulatory source

Guidebook on Channel Partner Training – Medical Devices (India)

APACMedOriginal source

🇺🇰Jul 13Industrygsk.comTier 1 · Company source

Jemperli (dostarlimab) achieves sustained clinical complete responses in dMMR/MSI-H locally advanced rectal cancer

GSK NewsOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Angelman clinical trial enrolls children to test new treatment

Angelman Syndrome NewsOriginal source

🌍Jul 13discoverynews.google.comTier 2 · Trade media

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

BioSpaceOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

AriBio receives remaining $50 mil. payment from Fosun for oral Alzheimer’s drug

koreabiomed.comOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Orders Recall of ₹2.45 Crore Worth of Aciloc Medicines Over Confusing Brand Names

Pune MirrorOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

TABLE-Cosmos Pharmaceutical -2025/26 parent results

TradingViewOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

COSMOS Pharmaceutical: Sales and profits rose on store growth, with FY2027 guidance for higher sales and dividends

TradingViewOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

HLB plunges as FDA rejects liver cancer drug; company pursues rapid reapproval - CHOSUNBIZ

ChosunbizOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

FDA Advisory No.2026-0778 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “STUNMEDICAL Line Fill Sub-Q Cross Linked Hyaluronic Acid with Lidocaine 1.0 mL”

fda.gov.phOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Celea doses first patient in phase 3 IPF drug trial By Investing.com

Investing.com IndiaOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Celea doses first patient in phase 3 IPF drug trial By Investing.com

Investing.com NigeriaOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Price to book forward of Trinity Biotech plc Sponsored ADR – FWB:TRB0

TradingViewOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Celea doses first patient in phase 3 IPF drug trial By Investing.com

Investing.com IndiaOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Celea Therapeutics Doses First Patient in Global Phase 3 SURPASS-IPF Trial Evaluating Deupirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Yahoo FinanceOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

PureTech Founded Entity Celea Therapeutics Doses First Patient in Global Phase 3 SURPASS-IPF Trial Evaluating Deupirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Business WireOriginal source

🌍Jul 13discoverynews.google.comTier 2 · Trade media

Third CRL For Elevar/Hengrui’s Liver Cancer Combo Regimen Over Manufacturing Issues

insights.citeline.comOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Paradigm Biopharmaceuticals Issues 3 Million PARAAD Convertible Notes at USD $1.00 Each on 13 July 2026

Kalkine MediaOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech Stock And 2 Biotech Names With Pipeline Catalysts

simplywall.stOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

FDA Drug Approval Decisions Expected in August 2026

Neurology AdvisorOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Bemotrizinol: Exploring the Newly Approved Sunscreen Active Ingredient

Dermatology AdvisorOriginal source

🇺🇸Jul 13Regulatoryfda.govTier 1 · Regulatory source

Pulmonary Valve Catheter Delivery System Recall: Medtronic Removes Harmony Delivery Catheter System (DCS)

The distal tip in certain lots of the Medtronic Harmony Delivery Catheter System (DCS) may detach wh...

FDA MedWatchOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

FDA Orders Recall of ₹2.45 Crore Worth of Aciloc Plus Medicines Over Risk of Medication Confusion

The Bridge ChronicleOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Paradigm Secures Fresh Funds to Advance Phase 3 Knee Osteoarthritis Trial

TipRanksOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Paradigm Biopharmaceuticals Issues 3 Million Convertible Notes at USD $1.00 Each, Advancing US$27M Phase 3 OA Trial Funding

KalkineOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

AstraZeneca licenses respiratory drug from Sino Biopharma in potential $1.9 billion deal

Indian Pharma PostOriginal source

🌍Jul 13Researchpnas.orgTier 2 · Direct publisher

Machine learning tracks neuronal patterns that hint at the biological basis for emotion

PNASOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Daewoong's Nabota tops ₩1tri. in cumulative sales, fuels global aesthetics ambitions

koreabiomed.comOriginal source

🌍Jul 13discoverynews.google.comTier 3 · Aggregated media

Aribio has received all $60 million (about 90 billion won) in advance of options under the global co..

매일경제Original source